5 min read
OutcomeRx, a division of CareMetx, LLC announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies
Launch of new reinsurance product will help payers manage sudden, high costs of therapies for rare genetic diseases with goal of reducing access and...

